US 10125172
Conformationally stabilized RSV pre-fusion F proteins
granted A61KA61K2039/525A61K39/12
Quick answer
US patent 10125172 (Conformationally stabilized RSV pre-fusion F proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/525, A61K39/12, A61K39/155, A61P